Updated PhRMA Code addresses company-sponsored speaker programs
By 
Jaclyn Jaeger2021-10-05T11:40:00
New voluntary standards issued by the Pharmaceutical Research and Manufacturers of America will soon take effect offering guidance related to company-sponsored speaker programs.
Related articles
-
ArticleRare OIG Special Fraud Alert cautions the use of speaker programs
In a rare move, the U.S. Department of Health and Human Services’ Office of Inspector General issued a Special Fraud Alert warning of inherent fraud and abuse risks associated with speaker programs.
-
ArticleMore than 100 ‘anticompetitive’ federal regulations poised for the chopping block
About 125 federal regulations deemed anticompetitive by President Trump are poised for possible elimination, following recommendations delivered Wednesday to the Office of Management and Budget (OMB).
-
PodcastListen to the radio interview with Compliance Week’s Aly McDevitt on Jeffrey Epstein
Jeffrey Epstein’s finances are back in the spotlight with new reports this month, but Compliance Week published an in-depth investigation into the anti-money laundering compliance angle of the story 18 months ago. Compliance Week’s Aly McDevitt went on WBAI Monday to discuss her investigation
More from Risk Management
-
PodcastStudy: Compliance managers must set rules in race to adopt AI agents and copilots
More than half of all compliance teams are “actively using” or “piloting” AI applications, according to a Moody’s report. While most are focusing on streamlining routine tasks, some are developing AI agents and asking vital questions about AI decision-making.
-
PremiumThanks to 'laser focus' on cartels, Trump admin creates new corporate risks in Mexico
The Trump administration’s designation of Mexican cartels as terrorist organizations in February has made doing business in Mexico riskier than ever before for corporations.
-
News BriefFederal Reserve Board drops reputational risk from exams, aligning with OCC and FDIC shift
Bank examiners at the Federal Reserve Board will no longer assess reputational risk during examinations, a concession to the banking industry already underway with two other U.S. regulators.